Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Edwards Lifesciences Corporation provides products and technologies for structural heart disease and critical care monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband names. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; INSPIRIS RESILLA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valves conduit for complex combined procedures; and MITRIS RESILIA valve. In addition, it offers critical care solutions, including hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings under the FloTrac, Acumen IQ sensors, ClearSight, Acumen IQ cuffs, and ForeSight names; HemoSphere, a monitoring platform that displays physiological information; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California. more
Time Frame | EW | Sector | S&P500 |
---|---|---|---|
1-Week Return | 4.25% | -3.72% | -0.05% |
1-Month Return | 5.75% | -1.85% | 2.75% |
3-Month Return | 6.56% | -11.4% | 7.4% |
6-Month Return | -14.92% | -4.41% | 10.47% |
1-Year Return | -1.3% | 4.13% | 27.57% |
3-Year Return | -38.19% | 0.3% | 29.56% |
5-Year Return | -5.63% | 36.62% | 89.3% |
10-Year Return | 253.52% | 106.81% | 206.09% |
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | 4.35B | 4.39B | 5.23B | 5.38B | 6.00B | [{"date":"2019-12-31","value":72.41,"profit":true},{"date":"2020-12-31","value":73.05,"profit":true},{"date":"2021-12-31","value":87.14,"profit":true},{"date":"2022-12-31","value":89.63,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Cost of Revenue | 1.11B | 1.08B | 1.25B | 1.08B | 1.38B | [{"date":"2019-12-31","value":80.77,"profit":true},{"date":"2020-12-31","value":78.32,"profit":true},{"date":"2021-12-31","value":90.51,"profit":true},{"date":"2022-12-31","value":78.3,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Gross Profit | 3.23B | 3.31B | 3.98B | 4.30B | 4.63B | [{"date":"2019-12-31","value":69.92,"profit":true},{"date":"2020-12-31","value":71.47,"profit":true},{"date":"2021-12-31","value":86.13,"profit":true},{"date":"2022-12-31","value":93.02,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Gross Margin | 74.37% | 75.36% | 76.13% | 79.93% | 77.02% | [{"date":"2019-12-31","value":93.05,"profit":true},{"date":"2020-12-31","value":94.29,"profit":true},{"date":"2021-12-31","value":95.25,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":96.36,"profit":true}] |
Operating Expenses | 1.99B | 1.99B | 2.40B | 2.51B | 2.90B | [{"date":"2019-12-31","value":68.88,"profit":true},{"date":"2020-12-31","value":68.67,"profit":true},{"date":"2021-12-31","value":82.75,"profit":true},{"date":"2022-12-31","value":86.76,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Operating Income | 1.15B | 1.63B | 1.35B | 1.75B | 1.53B | [{"date":"2019-12-31","value":65.59,"profit":true},{"date":"2020-12-31","value":93.13,"profit":true},{"date":"2021-12-31","value":77.12,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":87.74,"profit":true}] |
Total Non-Operating Income/Expense | 31.20M | 26.70M | 10.70M | 35.20M | 104.70M | [{"date":"2019-12-31","value":29.8,"profit":true},{"date":"2020-12-31","value":25.5,"profit":true},{"date":"2021-12-31","value":10.22,"profit":true},{"date":"2022-12-31","value":33.62,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Pre-Tax Income | 1.17B | 916.70M | 1.70B | 1.77B | 1.60B | [{"date":"2019-12-31","value":66,"profit":true},{"date":"2020-12-31","value":51.87,"profit":true},{"date":"2021-12-31","value":96.3,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":90.42,"profit":true}] |
Income Taxes | 119.60M | 93.30M | 198.90M | 245.50M | 198.70M | [{"date":"2019-12-31","value":48.72,"profit":true},{"date":"2020-12-31","value":38,"profit":true},{"date":"2021-12-31","value":81.02,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":80.94,"profit":true}] |
Income After Taxes | 1.05B | 823.40M | 1.50B | 1.52B | 1.40B | [{"date":"2019-12-31","value":68.79,"profit":true},{"date":"2020-12-31","value":54.1,"profit":true},{"date":"2021-12-31","value":98.76,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":91.95,"profit":true}] |
Income From Continuous Operations | 1.05B | 823.40M | 1.50B | 1.52B | 1.43B | [{"date":"2019-12-31","value":68.79,"profit":true},{"date":"2020-12-31","value":54.1,"profit":true},{"date":"2021-12-31","value":98.76,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":93.84,"profit":true}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | 1.05B | 823.40M | 1.50B | 1.52B | 1.40B | [{"date":"2019-12-31","value":68.79,"profit":true},{"date":"2020-12-31","value":54.1,"profit":true},{"date":"2021-12-31","value":98.76,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":92.15,"profit":true}] |
EPS (Diluted) | 1.86 | 1.85 | 2.23 | 2.48 | 2.51 | [{"date":"2019-12-31","value":74.1,"profit":true},{"date":"2020-12-31","value":73.71,"profit":true},{"date":"2021-12-31","value":88.84,"profit":true},{"date":"2022-12-31","value":98.8,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
These ratios help you determine the liquidity of the company. Higher is better.
EW | |
---|---|
Cash Ratio | 2.29 |
Current Ratio | 3.46 |
Quick Ratio | 2.89 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
EW | |
---|---|
ROA (LTM) | 10.65% |
ROE (LTM) | 19.14% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
EW | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.26 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.74 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
EW | |
---|---|
Trailing PE | 28.31 |
Forward PE | 30.30 |
P/S (TTM) | 6.85 |
P/B | 4.53 |
Price/FCF | 135 |
EV/R | 6.26 |
EV/Ebitda | 22.42 |
PEG | 6.73 |
Edwards Lifesciences Corp (EW) share price today is $73.91
Yes, Indians can buy shares of Edwards Lifesciences Corp (EW) on Vested. To buy Edwards Lifesciences Corp from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in EW stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of Edwards Lifesciences Corp (EW) via the Vested app. You can start investing in Edwards Lifesciences Corp (EW) with a minimum investment of $1.
You can invest in shares of Edwards Lifesciences Corp (EW) via Vested in three simple steps:
The 52-week high price of Edwards Lifesciences Corp (EW) is $96.12. The 52-week low price of Edwards Lifesciences Corp (EW) is $58.93.
The price-to-earnings (P/E) ratio of Edwards Lifesciences Corp (EW) is 28.3089
The price-to-book (P/B) ratio of Edwards Lifesciences Corp (EW) is 4.53
The dividend yield of Edwards Lifesciences Corp (EW) is 0.00%
The market capitalization of Edwards Lifesciences Corp (EW) is $43.24B
The stock symbol (or ticker) of Edwards Lifesciences Corp is EW